| [January 31, 2005] |
 |
Nexense Secures Equity Funding
NEW YORK --(Business Wire)-- Jan. 31, 2005 -- Nexense, an emerging sensing technology company, has raised equity funding in excess of $3 million from a group of private investors operating under Emmes, LLC, based in Chicago. The funds will be used to accelerate the commercialization of Nexense's patented technology, with an emphasis on the consumer health market.
"Nexense has demonstrated a high level of growth potential across several vertical industries and our investment will enable the company to grow faster, both domestically and internationally," said Arnold Thaler, Emmes, LLC. "In particular, the company's biosensor platform will enable the development of non-intrusive devices for home health monitoring, a sector that is rapidly expanding."
Nexense's biosensor platform is based on the company's patented method of measuring parameters such as temperature, acceleration, pressure, distance, weight and any other physical entities. Measurements are made in a direct digital manner and not constrained by the limitations of traditional sensor technologies.
"Nexense is at the final stage of product integration and customization for a number of its vital sign monitoring devices targeted for home use, which utilize our exclusive 3N technology so they are non-intrusive, non-contact and non-radiating," said Arik Ariav, CEO, Nexense. "This funding will enable us to move faster in adapting our technology to additional monitoring applications and to accelerate our market entry."
About Nexense
Created three years ago, Nexense's emerging sensing technology stretches the existing boundaries of measurement technology close to the theoretical limits, creating endless opportunities for new applications that were previously impossible to develop. The company partners with world leading companies in the areas of automotive, health care, aerospace and communications, enabling them to achieve higher profitability through low cost, high performance, robust and easy-to-use solutions.
Nexense (www.nexense.com) is based in both US and Israel with business operations in the US and an R&D facility in Israel.
[ Back To TMCnet.com's Homepage ]
|